Featured Showcase: Novel Technologies

Speaker: Tim Fugmann, PhD Business Development Director, Alithea Biotechnology GmbH

Presentation Highlights:

• Genomics vs. Real Data: Discover why large-scale HLA-peptidomics is the essential missing piece in traditional genomic workflows.

• Patient-Centric Validation: Review real patient peptide data that confirms which targets are actually being presented to the immune system—not just predicted by algorithms.

• Actionable Case Studies: Explore how our partners have used immunopeptidomics data to pivot project directions and accelerate clinical timelines.

“Immunopeptidomics reveals what peptides are actually presented to the immune system—not just what we predict might be there.” — Tim Fugmann, PhD

Why Join the 360° Audience?

Join over 600 attendees from pharma, biotech, and academia for a comprehensive look at the IO landscape.

• 100+ Sessions: From preclinical discovery to business development.

• Latest Data: Access cutting-edge clinical and preclinical insights from industry KOLs.

• High-Level Networking: Connect with investors and clinical trial leaders in the heart of Boston.

Exclusive Partner Offer

As a partner of Alithea Bio, you are eligible for an exclusive registration discount.

🎉 SAVE 20% ON YOUR PASS Use Registration Code: ALITHEA20

Location: Sheraton Boston Hotel, Boston, MA Register Today: Visit the IO360° Registration Portal